A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

Chemotherapy remains a primary cancer treatment. However, the poor selectivity of conventional small-molecule chemotherapeutic agents often leads to severe side effects against normal cells and tissues, limiting their clinical application. To address…

Preview only. Read the full abstract at the source